Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Jul;65(7):2593–2598. doi: 10.1128/iai.65.7.2593-2598.1997

Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.

N D Fedorova 1, S K Highlander 1
PMCID: PMC175367  PMID: 9199425

Abstract

An efficient method for targeted gene inactivation and generation of chromosomal gene fusions in Pasteurella haemolytica has been devised and used to create an lktC::cat operon fusion by allelic exchange at the leukotoxin gene cluster (lktCABD). A copy of the lktC gene was insertionally inactivated by using a nonpolar, promoterless cat cassette and then delivered into P. haemolytica on a shuttle vector. Plasmid incompatibility was used to detect clones where double recombination events had occurred at the chromosomal locus. The insertion in lktC did not affect expression of the downstream genes, and the mutant strain secreted an antigenic proleukotoxin that was neither leukotoxic nor hemolytic. Expression of the lktC gene in trans restored the wild-type phenotype, confirming that LktC is required for activation of the proleukotoxin to the mature leukotoxin. Construction of the lktC::cat operon fusion allowed us to quantitate leukotoxin promoter activity in P. haemolytica and to demonstrate that transcription was maximal during early logarithmic growth phase but was reduced following entry into late logarithmic phase. This allelic exchange system should be useful for future genetic studies in P. haemolytica and could potentially be applied to other members of Haemophilus-Actinobacillus-Pasteurella family, where genetic manipulation is limited.

Full Text

The Full Text of this article is available as a PDF (293.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azad A. K., Coote J. G., Parton R. Construction of conjugative shuttle and suicide vectors for Pasteurella haemolytica and P. multocida. Gene. 1994 Jul 22;145(1):81–85. doi: 10.1016/0378-1119(94)90326-3. [DOI] [PubMed] [Google Scholar]
  2. Briggs R. E., Tatum F. M., Casey T. A., Frank G. H. Characterization of a restriction endonuclease, PhaI, from Pasteurella haemolytica serotype A1 and protection of heterologous DNA by a cloned PhaI methyltransferase gene. Appl Environ Microbiol. 1994 Jun;60(6):2006–2010. doi: 10.1128/aem.60.6.2006-2010.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chang Y. F., Ma D. P., Bai H. Q., Young R., Struck D. K., Shin S. J., Lein D. H. Characterization of plasmids with antimicrobial resistant genes in Pasteurella haemolytica A1. DNA Seq. 1992;3(2):89–97. doi: 10.3109/10425179209034001. [DOI] [PubMed] [Google Scholar]
  4. Chang Y. F., Young R., Post D., Struck D. K. Identification and characterization of the Pasteurella haemolytica leukotoxin. Infect Immun. 1987 Oct;55(10):2348–2354. doi: 10.1128/iai.55.10.2348-2354.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Clinkenbeard K. D., Mosier D. A., Confer A. W. Transmembrane pore size and role of cell swelling in cytotoxicity caused by Pasteurella haemolytica leukotoxin. Infect Immun. 1989 Feb;57(2):420–425. doi: 10.1128/iai.57.2.420-425.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Confer A. W., Panciera R. J., Clinkenbeard K. D., Mosier D. A. Molecular aspects of virulence of Pasteurella haemolytica. Can J Vet Res. 1990 Apr;54 (Suppl):S48–S52. [PubMed] [Google Scholar]
  7. Conlon J. A., Shewen P. E., Lo R. Y. Efficacy of recombinant leukotoxin in protection against pneumonic challenge with live Pasteurella haemolytica A1. Infect Immun. 1991 Feb;59(2):587–591. doi: 10.1128/iai.59.2.587-591.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Craig F. F., Coote J. G., Parton R., Freer J. H., Gilmour N. J. A plasmid which can be transferred between Escherichia coli and Pasteurella haemolytica by electroporation and conjugation. J Gen Microbiol. 1989 Nov;135(11):2885–2890. doi: 10.1099/00221287-135-11-2885. [DOI] [PubMed] [Google Scholar]
  9. Diker K. S., Akan M., Haziroglu R. Antimicrobial susceptibility of Pasteurella haemolytica and Pasteurella multocida isolated from pneumonic ovine lungs. Vet Rec. 1994 Jun 4;134(23):597–598. doi: 10.1136/vr.134.23.597. [DOI] [PubMed] [Google Scholar]
  10. Dixon L. G., Albritton W. L., Willson P. J. An analysis of the complete nucleotide sequence of the Haemophilus ducreyi broad-host-range plasmid pLS88. Plasmid. 1994 Sep;32(2):228–232. doi: 10.1006/plas.1994.1060. [DOI] [PubMed] [Google Scholar]
  11. Dower W. J., Miller J. F., Ragsdale C. W. High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res. 1988 Jul 11;16(13):6127–6145. doi: 10.1093/nar/16.13.6127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fedorova N. D., Highlander S. K. Plasmids for heterologous expression in Pasteurella haemolytica. Gene. 1997 Feb 28;186(2):207–211. doi: 10.1016/s0378-1119(96)00704-4. [DOI] [PubMed] [Google Scholar]
  13. Forestier C., Welch R. A. Nonreciprocal complementation of the hlyC and lktC genes of the Escherichia coli hemolysin and Pasteurella haemolytica leukotoxin determinants. Infect Immun. 1990 Mar;58(3):828–832. doi: 10.1128/iai.58.3.828-832.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Frey J., van den Bosch H., Segers R., Nicolet J. Identification of a second hemolysin (HlyII) in Actinobacillus pleuropneumoniae serotype 1 and expression of the gene in Escherichia coli. Infect Immun. 1992 Apr;60(4):1671–1676. doi: 10.1128/iai.60.4.1671-1676.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gentry M. J., Srikumaran S. Neutralizing monoclonal antibodies to Pasteurella haemolytica leukotoxin affinity-purify the toxin from crude culture supernatants. Microb Pathog. 1991 May;10(5):411–417. doi: 10.1016/0882-4010(91)90086-p. [DOI] [PubMed] [Google Scholar]
  16. Gutterson N. I., Koshland D. E., Jr Replacement and amplification of bacterial genes with sequences altered in vitro. Proc Natl Acad Sci U S A. 1983 Aug;80(16):4894–4898. doi: 10.1073/pnas.80.16.4894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Highlander S. K., Chidambaram M., Engler M. J., Weinstock G. M. DNA sequence of the Pasteurella haemolytica leukotoxin gene cluster. DNA. 1989 Jan-Feb;8(1):15–28. doi: 10.1089/dna.1.1989.8.15. [DOI] [PubMed] [Google Scholar]
  18. Highlander S. K., Engler M. J., Weinstock G. M. Secretion and expression of the Pasteurella haemolytica Leukotoxin. J Bacteriol. 1990 May;172(5):2343–2350. doi: 10.1128/jb.172.5.2343-2350.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Highlander S. K., Garza O. The restriction-modification system of Pasteurella haemolytica is a member of a new family of type I enzymes. Gene. 1996 Oct 31;178(1-2):89–96. doi: 10.1016/0378-1119(96)00340-x. [DOI] [PubMed] [Google Scholar]
  20. Highlander S. K., Weinstock G. M. Static DNA bending and protein interactions within the Pasteurella haemolytica leukotoxin promoter region: development of an activation model for leukotoxin transcriptional control. DNA Cell Biol. 1994 Feb;13(2):171–181. doi: 10.1089/dna.1994.13.171. [DOI] [PubMed] [Google Scholar]
  21. Highlander S. K., Wickersham E. A., Garza O., Weinstock G. M. Expression of the Pasteurella haemolytica leukotoxin is inhibited by a locus that encodes an ATP-binding cassette homolog. Infect Immun. 1993 Sep;61(9):3942–3951. doi: 10.1128/iai.61.9.3942-3951.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Homchampa P., Strugnell R. A., Adler B. Construction and vaccine potential of an aroA mutant of Pasteurella haemolytica. Vet Microbiol. 1994 Sep;42(1):35–44. doi: 10.1016/0378-1135(94)90075-2. [DOI] [PubMed] [Google Scholar]
  23. Issartel J. P., Koronakis V., Hughes C. Activation of Escherichia coli prohaemolysin to the mature toxin by acyl carrier protein-dependent fatty acylation. Nature. 1991 Jun 27;351(6329):759–761. doi: 10.1038/351759a0. [DOI] [PubMed] [Google Scholar]
  24. Lo R. Y., Strathdee C. A., Shewen P. E. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect Immun. 1987 Sep;55(9):1987–1996. doi: 10.1128/iai.55.9.1987-1996.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lukomski S., Hull R. A., Hull S. I. Identification of the O antigen polymerase (rfc) gene in Escherichia coli O4 by insertional mutagenesis using a nonpolar chloramphenicol resistance cassette. J Bacteriol. 1996 Jan;178(1):240–247. doi: 10.1128/jb.178.1.240-247.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Murphy G. L., Whitworth L. C., Clinkenbeard K. D., Clinkenbeard P. A. Hemolytic activity of the Pasteurella haemolytica leukotoxin. Infect Immun. 1995 Aug;63(8):3209–3212. doi: 10.1128/iai.63.8.3209-3212.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Murphy G. L., Whitworth L. C. Construction of isogenic mutants of Pasteurella haemolytica by allelic replacement. Gene. 1994 Oct 11;148(1):101–105. doi: 10.1016/0378-1119(94)90241-0. [DOI] [PubMed] [Google Scholar]
  28. Petras S. F., Chidambaram M., Illyes E. F., Froshauer S., Weinstock G. M., Reese C. P. Antigenic and virulence properties of Pasteurella haemolytica leukotoxin mutants. Infect Immun. 1995 Mar;63(3):1033–1039. doi: 10.1128/iai.63.3.1033-1039.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ruvkun G. B., Ausubel F. M. A general method for site-directed mutagenesis in prokaryotes. Nature. 1981 Jan 1;289(5793):85–88. doi: 10.1038/289085a0. [DOI] [PubMed] [Google Scholar]
  30. Shaw W. V. Chloramphenicol acetyltransferase from chloramphenicol-resistant bacteria. Methods Enzymol. 1975;43:737–755. doi: 10.1016/0076-6879(75)43141-x. [DOI] [PubMed] [Google Scholar]
  31. Shewen P. E., Wilkie B. N. Cytotoxin of Pasteurella haemolytica acting on bovine leukocytes. Infect Immun. 1982 Jan;35(1):91–94. doi: 10.1128/iai.35.1.91-94.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Shewen P. E., Wilkie B. N. Evidence for the Pasteurella haemolytica cytotoxin as a product of actively growing bacteria. Am J Vet Res. 1985 May;46(5):1212–1214. [PubMed] [Google Scholar]
  33. Stevens P. K., Czuprynski C. J. Pasteurella haemolytica leukotoxin induces bovine leukocytes to undergo morphologic changes consistent with apoptosis in vitro. Infect Immun. 1996 Jul;64(7):2687–2694. doi: 10.1128/iai.64.7.2687-2694.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Strathdee C. A., Lo R. Y. Extensive homology between the leukotoxin of Pasteurella haemolytica A1 and the alpha-hemolysin of Escherichia coli. Infect Immun. 1987 Dec;55(12):3233–3236. doi: 10.1128/iai.55.12.3233-3236.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Strathdee C. A., Lo R. Y. Regulation of expression of the Pasteurella haemolytica leukotoxin determinant. J Bacteriol. 1989 Nov;171(11):5955–5962. doi: 10.1128/jb.171.11.5955-5962.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tatum F. M., Briggs R. E., Halling S. M. Molecular gene cloning and nucleotide sequencing and construction of an aroA mutant of Pasteurella haemolytica serotype A1. Appl Environ Microbiol. 1994 Jun;60(6):2011–2016. doi: 10.1128/aem.60.6.2011-2016.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wagner W., Kuhn M., Goebel W. Active and inactive forms of hemolysin (HlyA) from Escherichia coli. Biol Chem Hoppe Seyler. 1988 Jan;369(1):39–46. doi: 10.1515/bchm3.1988.369.1.39. [DOI] [PubMed] [Google Scholar]
  38. Waurzyniak B. J., Clinkenbeard K. D., Confer A. W., Srikumaran S. Enhancement of Pasteurella haemolytica leukotoxic activity by bovine serum albumin. Am J Vet Res. 1994 Sep;55(9):1267–1274. [PubMed] [Google Scholar]
  39. Welch R. A. Pore-forming cytolysins of gram-negative bacteria. Mol Microbiol. 1991 Mar;5(3):521–528. doi: 10.1111/j.1365-2958.1991.tb00723.x. [DOI] [PubMed] [Google Scholar]
  40. West S. E., Romero M. J., Regassa L. B., Zielinski N. A., Welch R. A. Construction of Actinobacillus pleuropneumoniae-Escherichia coli shuttle vectors: expression of antibiotic-resistance genes. Gene. 1995 Jul 4;160(1):81–86. doi: 10.1016/0378-1119(95)00236-y. [DOI] [PubMed] [Google Scholar]
  41. Wood A. R., Lainson F. A., Wright F., Baird G. D., Donachie W. A native plasmid of Pasteurella haemolytica serotype A1: DNA sequence analysis and investigation of its potential as a vector. Res Vet Sci. 1995 Mar;58(2):163–168. doi: 10.1016/0034-5288(95)90071-3. [DOI] [PubMed] [Google Scholar]
  42. Wright C. L., Strugnell R. A., Hodgson A. L. Characterization of a Pasteurella multocida plasmid and its use to express recombinant proteins in P. multocida. Plasmid. 1997;37(1):65–79. doi: 10.1006/plas.1996.1276. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES